Cybin to participate in the h.c. wainwright 5th annual neuro perspectives virtual conference

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, will participate in a fireside chat at the h.c. wainwright 5th annual neuro perspectives virtual conference, taking place june 27, 2024. mr. drysdale's.
CYBN Ratings Summary
CYBN Quant Ranking